US Broker Ratings

Elanco Animal Health (ELAN): Investor Outlook on Strong Buy Ratings and Robust Growth Potential

Elanco Animal Health Incorporated (NYSE: ELAN) is capturing investor attention with its strong buy ratings and substantial growth potential, reflecting a promising outlook for the company...

Moderna, Inc. (MRNA) Investor Outlook: Assessing the Biotech Giant Amidst Revenue Decline and Market Volatility

Moderna, Inc. (NASDAQ: MRNA) has made headlines since the onset of the COVID-19 pandemic, leveraging its mRNA technology to become a household name. However, as the..

Revvity, Inc. (RVTY) Stock Analysis: Navigating a 22.53% Upside Potential in the Healthcare Diagnostics Sector

Revvity, Inc. (RVTY), a notable player in the healthcare diagnostics and research sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry. With..

BioNTech SE (BNTX) Stock Analysis: Navigating Challenges with a 28.64% Potential Upside

BioNTech SE (NASDAQ: BNTX), a recognized leader in biotechnology based in Germany, has been making waves in the healthcare sector with its pioneering work in immunotherapy..

HealthEquity, Inc. (HQY) Investor Outlook: 31% Upside Potential Drives Strong Buy Ratings

HealthEquity, Inc. (NASDAQ: HQY), a leader in the Health Information Services industry, is capturing investor attention with its promising growth potential and dominant position in the..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 14.17% Potential Upside in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, is capturing investor attention with its robust market position and potential for a 14.17% upside...

Biogen Inc. (BIIB) Stock Analysis: Navigating a 17% Potential Upside Amidst Market Challenges

Biogen Inc. (BIIB), a prominent player in the healthcare sector, stands out in the drug manufacturing industry despite facing recent headwinds. With a market capitalization of..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating Growth Potential Amid a 24.14% Upside

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, is capturing investor attention with its potential upside of 24.14%, as suggested by analysts’ target..

Chemed Corp (CHE) Stock Analysis: Evaluating a 15% Growth Potential Amidst Stable Healthcare Services

Investors looking to explore opportunities in the healthcare sector might find Chemed Corp (NYSE: CHE) an intriguing prospect. With its diverse business operations spanning hospice care..

Summit Therapeutics Inc. (SMMT): Investor Outlook on This Biotech Stock with 23.70% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) has caught the attention of investors in the biotech sector, thanks to its promising pipeline and potential upside of 23.70%. Let’s..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a 59% Potential Upside for Investors

For investors with an eye on the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) offers a compelling opportunity. With its strategic position in the medical instruments..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatility with a 52-Week Range from $0.76 to $78.00

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), has captured the attention of investors with its dramatic 52-week..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a Healthcare Giant with a 1.16% Upside Potential

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a prominent figure in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $8.07..

Illumina, Inc. (ILMN) Stock Analysis: Balancing Innovation in Genomics with Market Volatility

Illumina, Inc. (NASDAQ: ILMN) stands at the forefront of genomic innovation, providing sequencing and array-based solutions that are pivotal for genetic and genomic analysis across the..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Challenges with Strategic Alliances

Charles River Laboratories International, Inc. (CRL) has long been a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Boasting a market..

Alcon Inc. (ALC) Stock Analysis: A 16.43% Potential Upside in the Healthcare Sector

Alcon Inc. (NYSE: ALC), a leading player in the healthcare sector, particularly in the medical instruments and supplies industry, presents a compelling opportunity for investors with..

Veeva Systems Inc. (VEEV) Investor Outlook: Unpacking a 58.28% Potential Upside

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable force in the health information services industry, known for its innovative cloud-based solutions catering to the life..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 8.39% Potential Upside in Precision Oncology

Investors with a keen eye on the biotechnology sector are likely to find Revolution Medicines, Inc. (NASDAQ: RVMD) a compelling prospect. Headquartered in Redwood City, California,..

Hologic, Inc. (HOLX) Stock Analysis: Evaluating the Growth Potential in the Medical Instruments Sector

Hologic, Inc. (NASDAQ: HOLX) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Doximity, Inc. (DOCS) Stock Analysis: Assessing a 54.89% Potential Upside in the Healthcare Sector

Doximity, Inc. (NYSE: DOCS), a leading player in the healthcare information services industry, presents an intriguing opportunity for investors seeking exposure in the digital health sector...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds